Aley K O, Levine J D
Department of Anatomy, Medicine, and Oral Surgery and Division of Neuroscience, University of California, San Francisco, California 94143, USA.
J Neurosci. 1997 Oct 15;17(20):8018-23. doi: 10.1523/JNEUROSCI.17-20-08018.1997.
The mu-opioid [D-Ala2,N-Me-Phe4,Gly-ol5]-enkephalin (DAMGO) exerts a peripheral antinociceptive effect against prostaglandin E2 (PGE2)-induced mechanical hyperalgesia in the hindpaw of the rat. Tolerance and dependence develop to this effect. We have shown previously that tolerance and dependence can be dissociated and are mediated by different second messenger systems. In the present study, we evaluated whether the same or different second messenger systems mediate the development of this peripheral opioid tolerance or dependence compared with the expression of the loss of antinociceptive effect or rebound opioid antagonist hyperalgesia (i. e., expression of tolerance and dependence). DAMGO-induced tolerance was prevented by pretreatment with the nitric oxide synthase inhibitor NG-methyl-L-arginine (NMLA) but not by the protein kinase C (PKC) inhibitor chelerythrine, the adenylyl cyclase inhibitor 2',5'-dideoxyadenosine (ddA), or the calcium chelators 3,4,5-trimethoxybenzoic acid 8-(diethylamino)-octyl ester (TMB-8) and 2-[(2-bis-[carboxymethyl]amino-5-methylphenoxy)-methyl]-6-methoxy-8-bis [carboxymethyl]aminoquinoline (Quin-2). Once established, however, expression of DAMGO tolerance was acutely reversed by TMB-8 or Quin-2 but not by chelerythrine or NMLA. In contrast, naloxone-precipitated hyperalgesia in DAMGO-tolerant paws, a measure of dependence, was blocked by pretreatment with chelerythrine but not by NMLA, ddA, TMB-8, or Quin-2. Naloxone-precipitated hyperalgesia in DAMGO-tolerant paws was acutely reversed by chelerythrine, ddA, TMB-8, or Quin-2 but not by NMLA. Taken together, these results provide the first evidence that different mechanisms mediate the development and expression of both tolerance and dependence to the peripheral antinociceptive effect of DAMGO. However, although the development of tolerance and dependence are entirely separable, the expression of tolerance and dependence shares common calcium-dependent mechanisms.
μ-阿片样物质[D-丙氨酸2,N-甲基苯丙氨酸4,甘醇5]-脑啡肽(DAMGO)对前列腺素E2(PGE2)诱导的大鼠后爪机械性痛觉过敏具有外周抗伤害感受作用。对此作用会产生耐受性和依赖性。我们之前已经表明,耐受性和依赖性可以分离,且由不同的第二信使系统介导。在本研究中,我们评估了与抗伤害感受作用丧失或阿片类拮抗剂反弹性痛觉过敏的表达(即耐受性和依赖性的表达)相比,相同或不同的第二信使系统是否介导这种外周阿片类耐受性或依赖性的发展。一氧化氮合酶抑制剂NG-甲基-L-精氨酸(NMLA)预处理可预防DAMGO诱导的耐受性,但蛋白激酶C(PKC)抑制剂白屈菜红碱、腺苷酸环化酶抑制剂2',5'-二脱氧腺苷(ddA)或钙螯合剂3,4,5-三甲氧基苯甲酸8-(二乙氨基)辛酯(TMB-8)和2-[(2-双-[羧甲基]氨基-5-甲基苯氧基)-甲基]-6-甲氧基-8-双[羧甲基]氨基喹啉(喹啉-2)则不能。然而,一旦建立,DAMGO耐受性的表达可被TMB-8或喹啉-2急性逆转,但不能被白屈菜红碱或NMLA逆转。相比之下,在DAMGO耐受的爪子中,纳洛酮诱发的痛觉过敏(一种依赖性的指标)可被白屈菜红碱预处理阻断,但不能被NMLA、ddA、TMB-8或喹啉-2阻断。在DAMGO耐受的爪子中,纳洛酮诱发的痛觉过敏可被白屈菜红碱、ddA、TMB-8或喹啉-2急性逆转,但不能被NMLA逆转。综上所述,这些结果首次证明,不同机制介导了对DAMGO外周抗伤害感受作用的耐受性和依赖性的发展及表达。然而,尽管耐受性和依赖性的发展完全可分离,但耐受性和依赖性的表达具有共同的钙依赖性机制。